By Jason Napodano, CFA
This morning, Cipher Pharmaceuticals (DND.TO) (CPHMF.PK) posted an updated investor presentation on its website. It shows that business is chugging along nicely at Cipher. Back in May 2013, we announced that we were raising our earnings forecasts for the company, yet again, after a solid first quarter 2013 report. In the first quarter 2013, Cipher delivered $3.3 million in revenues and $1.5 million in net income (+6 cents per share). Revenues increased by 82% over the first quarter 2012. It was the fifth quarter in a row of greater than 80% year-over-year revenue growth and the fifth quarter in a row of positive earnings per share.
The new investor presentation highlights many of the impressive business...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|